Page last updated: 2024-12-05
2,6-difluorobenzoic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2,6-difluorobenzoic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9796 |
SCHEMBL ID | 260553 |
MeSH ID | M0206954 |
Synonyms (40)
Synonym |
---|
nsc-126584 |
benzoic acid,6-difluoro- |
nsc126584 |
385-00-2 |
2,6-difluorobenzoic acid |
benzoic acid, 2,6-difluoro- |
brn 0973774 |
einecs 206-856-3 |
ai3-63060 |
nsc 126584 |
inchi=1/c7h4f2o2/c8-4-2-1-3-5(9)6(4)7(10)11/h1-3h,(h,10,11 |
2,6-difluorobenzoic acid, 98% |
AC-2898 |
D1629 |
STK802604 |
AKOS000119515 |
95b9m9kuy5 , |
unii-95b9m9kuy5 |
2,6-difluorobenzoate calcium dihydrate |
3-09-00-01330 (beilstein handbook reference) |
FT-0610648 |
2,6-difluorobenzoicacid |
AM62241 |
TD1186 |
CS-M0554 |
SCHEMBL260553 |
2,6-difluoro benzoic acid |
2,6,-difluorobenzoic acid |
2,6-difluoro-benzoic acid |
Q-200211 |
BS-3869 |
mfcd00002411 |
DTXSID7075391 |
F2191-0055 |
SY003297 |
cga 149776 |
EN300-20036 |
A856661 |
difluorobenzoic acid, 2,6- |
Z104476530 |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" The metabolic fate of the insecticide teflubenzuron, orally dosed to the male Wistar rat, was investigated." | ( Metabolism of the insecticide teflubenzuron in rats. Cnubben, NH; De Kraker, JW; Koerts, J; Rietjens, IM; Soffers, AE, 1997) | 0.3 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 24.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.56) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |